近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Davidson, A., Veillard, A.-S., Tognela, A., Chan, M. M. K., Hughes, B. G. M., Boyer, M., … Stockler, M. R. (2015). A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial. Annals of Oncology, 26(11), 2280–2286. Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., … Abdi, E. (2014). Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet, 383(9922), 1041–1048. Hertzberg, M., Matthews, J. P., Stone, J. M., Dubosq, M.-C., Grigg, A., Ellis, D., … Wolf, M. (2014). A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. American Journal of Hematology, 89(5), 536–541. Hovey, E., Souza, P., Marx, G., Parente, P., Rapke, T., Hill, A., … Lloyd, A. (2014). Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy. Supportive Care in Cancer, 22(5), 1233–1242. McCarthy, N., Boyle, F., Zdenkowski, N., Bull, J., Leong, E., Simpson, A., … Forbes, J. (2014). Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). The Breast, 23(2), 142–151.